← All organizations
Highest phase reached
Phase 2
First clinical trial
Jul 1, 2019Last known activity
May 12, 2023
Acquired by Sumitomo Dainippon on Sep 6, 2019
Timeline
2010s
- Jun 1, 2018
Altavant— Founded
- Sep 6, 2019
Sumitomo Dainippon— Acquired By
Drugs by trial phase (3 distinct, 6 trials)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (8)
- NCT05933447Lead sponsorPhase 1May 12, 2023
- NCT05684640Lead sponsorPhase 1Sep 29, 2022
- NCT05065359CollaboratorPhase 1Oct 1, 2021
- NCT05065359Lead sponsorPhase 1Oct 1, 2021
- NCT05006118CollaboratorPhase 1Sep 1, 2021
- NCT05006118Lead sponsorPhase 1Sep 1, 2021
- NCT04712669Lead sponsorPhase 2Mar 15, 2021
- NCT03924154Lead sponsorPhase 2Jul 1, 2019
Details
- Founded
- Cary, NC, US Jun 1, 2018
- Last known activity
- May 12, 2023